Author

Thomas Hoogenboezem

ProQR Therapeutics (Netherlands)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andrew R. WebsteriD· 1 shared Davide PiccoloiD· 1 shared Gerard J. PlatenburgiD· 1 shared Jim SwildensiD· 1 shared Kalyan Dulla· 1 shared Melita KaltakiD· 1 shared Michael E. CheethamiD· 1 shared Petra de Bruijn· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andrew R. WebsterORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antisense oligonucleotide therapy for the common Stargardt disease type 1-causing variant in ABCA4

Melita Kaltak, Petra de Bruijn, Davide Piccolo, Sang-Eun Lee, Kalyan Dulla, Thomas Hoogenboezem, Wouter Beumer, Andrew R. Webster, Rob W.J. Collin, Michael E. Cheetham, Gerard J. Platenburg, Jim Swildens

This study demonstrates that antisense oligonucleotides can correct splicing defects in the ABCA4 c.5461-10T>C variant, restoring protein function in retinal organoids.

bioRxiv · Aug 12, 2022 · PreprintMolecular Biology